We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Digital Holographic Microscopy Reveals How Cancer Cells Gain Extra Chromosomes

By LabMedica International staff writers
Posted on 22 Nov 2010
Cell biologists have used digital holographic microscopy to show how abnormal distribution of chromosomes takes place in some types of cancer cells.

Investigators at Lund University (Sweden) used Wilms' tumor as a model for cancers with trisomies. More...
They made movies of the tumor cells growing in culture. To prevent damage to the cells during photography, they employed digital holographic microscopy, a novel technique by which the cells were exposed only to weak laser light for very limited time periods.

Results published in the November 8, 2010, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS) contrasted with the popular theory that dysfunction of the spindle assembly checkpoint (SAC) leads to an accumulation of trisomies through failure to correctly segregate sister chromatids in successive cell divisions. Instead, results of the current study showed that trisomic cells could form even in the presence of a functional SAC through tripolar cell divisions in which sister chromatid separation proceeded in a regular fashion, but cytokinesis failure nevertheless led to an asymmetrical segregation of chromosomes into two daughter cells.

"We were even more surprised to see that two of the three poles often fused together to form one daughter cell. This daughter cell thus got extra copies of one or more chromosomes. When we continued to film the cells it emerged that they could continue to divide, and they thus gave rise to new cancer cells with a chromosome set that was different from the original cell,” said first author Dr. David Gisselsson Nord, associate professor of pathology at the Lund University.

"We have long known that changes in the genetic make-up of body cells play a part in the development of tumors. However, we do not know a lot about how the genetic changes in the tumor cells actually come about. Above all, it has been difficult to understand why many tumor cells contain extra copies of one or more chromosomes, despite the fact that this is the most common type of chromosome abnormality in cancer cells,” said Dr. Nord.

Related Links:
Lund University



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
STI Test
REALQUALITY RQ-SevenSTI
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Switching to an experimental drug after liquid biopsy detection of breast cancer recurrence can improve outcomes (Photo courtesy of Shutterstock)

Treatment Switching Guided by Liquid Biopsy Blood Tests Improves Outcomes for Breast Cancer Patients

Standard treatment for patients with advanced estrogen receptor (ER)-positive, HER2-negative breast cancer, a subtype driven by estrogen receptors that fuel tumor growth, often involves aromatase inhibitors,... Read more

Pathology

view channel
Image: A new at-home self-collection device aims to reduce the screening gap for cervical cancer (Photo courtesy of CU School of Medicine)

New At-Home Cervical Cancer Screening Device to Increase Accessibility for Patients

Cervical cancer is typically linked to certain types of human papillomavirus (HPV), which is passed through sexual contact. While many people are infected with HPV, only a small percentage will develop... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.